# A Safety Study of Mebendazole in Children 2 to 10 Years of Age

> **NCT01173562** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 397 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Mebendazole

## Key facts

- **NCT ID:** NCT01173562
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 397 (ACTUAL)
- **Last updated:** 2014-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173562, "A Safety Study of Mebendazole in Children 2 to 10 Years of Age". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01173562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*